Atavistik
PrivateLast Round
Series B
3/5/2026
Total Funding Raised
$380M
Company Overview
Atavistik Bio is a biopharmaceutical company dedicated to discovering and developing innovative therapies for metabolic diseases and cancer, utilizing nature-inspired allosteric control mechanisms to target genetically validated pathways.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Atavistik Comps
Public and private peers based on sector, stage, and business model.
Atavistik Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | 3/5/2026 | ||||
| Series B | 12/18/2025 | ||||
| Series A Extension | 12/19/2023 | ||||
| Series A | 8/24/2021 |
Key People
Founding team and executive leadership
Atavistik Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Column Group | Series B, Series A, Series A Extension |
| RA Capital Management | Series B |
| Regeneron Ventures | Series B |
| Lux Capital | Series A, Series B, Series A Extension |
| The Chernin Group | Series A, Series A Extension |
| Nextech Invest | Series A, Series B, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 16, 2026
Agent ZE74-0282 is currently in Phase I clinical trials.
- Mar 16, 2026
Advancing an allosteric JAK2 V617F inhibitor toward clinical proof of concept.
Atavistik Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Atavistik's valuation, stock price, and market status.
